Gainers
- Akerna Corp. KERN shares surged 224.4% to close at $49.80 on Wednesday.
- Melinta Therapeutics, Inc. MLNT shares jumped 223.7% to close at $6.41 on Wednesday after the company reported FDA approval of its BAXDELA sNDA for the treatment of community acquired bacterial pneumonia.
- Foresight Autonomous Holdings Ltd. FRSX shares gained 40.4% to close at $1.32 after the company signed a commercial agreement with Elbit Systems for exclusive marketing of its software for the defense market.
- AquaBounty Technologies, Inc. AQB gained 39.9% to close at $3.12.
- Arcturus Therapeutics Holdings Inc ARCT climbed 36.7% to close at $7.90 after the company expanded its research collaboration and licensing agreement with Ultragenyx to develop nucleic acid therapies. The company will receive upfront payments and an equity investment.
- MYOS Corporation MYOS climbed 26.9% to close at $1.70 after the company disclosed positive top-line results from a study evaluating the impact of Fortetropin on the rate of muscle protein synthesis in older men and women.
- Vuzix Corporation VUZI surged 18.6% to close at $4.40.
- Verb Technology Company, Inc. VERB gained 17.3% to close at $2.58.
- Armata Pharmaceuticals, Inc. ARMP shares rose 17.5% to close at $3.36.
- Moxian, Inc. MOXC rose 16.8% to close at $3.20.
- Revolve Group, Inc. RVLV jumped 15% to close at $46.96.
- Savara Inc. SVRA shares gained 13.9% to close at $2.71.
- Axalta Coating Systems Ltd. AXTA gained 13.6% to close at $29.33 after the company announced it has initiated a review of strategic alternatives to maximize shareholder value.
- LSC Communications, Inc. LKSD rose 11% to close at $5.76.
- Tilray, Inc. TLRY rose 10.8% to close at $45.47.
- AVROBIO, Inc. AVRO shares jumped 10.6% to close at $14.61.
- Jabil Inc. JBL gained 10.3% to close at $30.12. Jabil reported in-line earnings for its third quarter, while sales exceeded estimates. The company also issued in-line Q4 guidance.
- Nabors Industries Ltd. NBR shares rose 10.3% to close at $2.4700.
- ATA Inc. ATAI surged 10.2% to close at $2.48.
- Kandi Technologies Group, Inc. KNDI shares rose 10% to close at $5.16.
- CannTrust Holdings Inc CTST gained 8.9% to close at $5.37 after the company announced Wednesday its entrance to the U.S. market, starting in the state of California.
- La-Z-Boy Incorporated LZB rose 8.9% to close at $32.45 after the company reported Q4 EPS and sales results.
- Dyadic International, Inc. DYAI gained 7.6% to close at $6.95.
- Zynex, Inc. ZYXI rose 5.7% to close at $10.38.
- Adobe Inc. ADBE rose 5.2% to close at $291.21 after the company reported better-than-expected Q2 EPS and sales results.
- Nabriva Therapeutics plc NBRV gained 4.8% to close at $2.20 after the company reported submission of FDA Type-A meeting request for intravenous CONTEPO.
- Arch Coal, Inc. ARCH gained 4.4% to close at $94.41 after the company announced it would combine with Peabody Energy for a joint venture.
- United States Steel Corporation X shares rose 4.1% to close at $15.17. US Steel projects Q2 adjusted earnings of $0.40 per share and adjusted EBITDA of $250 million.
Losers
- Jensyn Acquisition Corp. JSYN shares fell 45.7% to close at $5.03. After the closing bell, Jensyn Acquisition reported that the shareholders had approved a merger with peck Electric.
- Legacy Reserves Inc. LGCY dropped 27.6% to close at $0.0790 on Wednesday after the company filed for chapter 11 bankruptcy protection.
- Genocea Biosciences Inc GNCA shares declined 24.8% to close at $3.8500 after the company reported a 10 million shares common stock offering.
- MoneyGram International, Inc. MGI shares dropped 24.5% to close at $2.9300 on Wednesday after climbing 167.59% on Tuesday.
- Cherokee Inc CHKE fell 24.4% to close at $0.6050 after the company reported worse-than-expected Q1 EPS and sales results.
- Sesen Bio Inc SESN shares dipped 19.6% to close at $1.48 on Wednesday. Sesen Bio priced its 20.41 million share offering at $1.47 per share.
- Greenlane Holdings, Inc. GNLN dropped 17.1% to close at $11.00.
- Calithera Biosciences, Inc. CALA fell 13.7% to close at $4.0900 after the company priced its 12.5 million share offering of common stock at $4.00 per share.
- QuickLogic Corporation QUIK fell 13.7% to close at $0.6130 after the company announced the pricing of a 16 million share common stock offering at $0.50 per share, which will result in approximately $8 million in gross proceeds from the offering.
- Intec Pharma Ltd. NTEC dipped 12.6% to close at $4.18.
- Sophiris Bio, Inc. SPHS fell 11.4% to close at $0.8591 after the company received EMA feedback on its Phase 3 prostate cancer trial design. The company expects data from a single phase 3 trial, if successful, will be sufficient to support marketing approval in Europe.
- ContraVir Pharmaceuticals, Inc. CTRV shares fell 10.6% to close at $4.7400.
- Synalloy Corporation SYNL shares fell 10.3% to close at $15.11. Synalloy cut FY2019 guidance from $30.037 million to $21.904 million. Synalloy cut its net income guidance from $9.331 million to $2.779 million.
- China Customer Relations Centers, Inc. CCRC dropped 9.9% to close at $10.37.
- Resonant Inc. RESN dropped 9.8% to close at $2.12.
- MOGU Inc. MOGU shares slipped 9.3% to close at $3.03.
- Zymeworks Inc. ZYME fell 9.2% to close at $18.31. Zymeworks filed prospectus supplements for offering of common shares and pre-funded warrants.
- Spherix Incorporated SPEX dipped 8.9% to close at $2.4600.
- Green Plains Inc. GPRE dropped 8.7% to close at $11.38. Green Plains announced plans to suspend quarterly dividend and priced offering of $105 million aggregate principal amount of 4.00% convertible senior notes due 2024.
- Lonestar Resources US Inc. LONE dropped 8.5% to close at $2.7100.
- GWG Holdings, Inc. GWGH declined 8.4% to close at $8.24.
- YY Inc. YY fell 8% to close at $71.04 after the company reported a proposed offering of US$850 million convertible senior note.
- Global Cord Blood Corporation CO shares declined 7.3% to close at $5.35 after the company reported worse-than-expected Q4 EPS and sales results.
- Jaguar Health, Inc. JAGX dropped 7.3% to close at $5.21. Jaguar Health reported key finding for final canalevia technical section for proposed indication of chemotherapy-induced diarrhea in dogs.
- Cesca Therapeutics Inc. KOOL fell 7.1% to close at $2.88 after rising 11.11% on Tuesday.
- Energizer Holdings, Inc. ENR fell 6.3% to close at $39.20. JP Morgan downgraded Energizer from Neutral to Underweight and lowered the price target from $45 to $36.
- The Lovesac Company LOVE fell 6% to close at $31.30.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneralConsumer DiscretionaryEnergyHome FurnishingsLosersMovers From WednesdayMovers From YesterdayOil & Gas DrillingOil & Gas Exploration & ProductionTop GainersYesterday's Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in